← SynDRA
FIDAXOMICIN
SynDRA canonical compound SYN0024574 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | RNA polymerase inhibitor |
|---|
| Indication | diarrhea |
|---|
| Disease area | gastroenterology |
|---|
All known targets
Mechanisms of action (all sources)
- RNA polymerase inhibitor
- rpoZ INHIBITOR
- rpoB INHIBITOR
- rpoC INHIBITOR
- rpoA INHIBITOR
Drug classes
- Macrolide Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- INTESTINAL ANTIINFECTIVES
Cross-references
Synonyms
- lipiarmicin
- lipiarmycin
- tiacumicin B
- dificid
- dificlir
- Fidaxomicine
- Fidaxomicina
- OPT-80
- PAR-101
- Dificid
- Dificlir
- Dificid (TN)
- Z5N076G8YQ
- OPT 80
- PAR 101
- Tiacumicin B
- Lipiarmicin
- Difimicin
- fidaxomicine
- Lipiarmycin A3
- CHEBI:68590
- fidaxomicinum
- OPT80 cpd
- RefChem:57141
- PAR101
- A07AA12
- DTXCID801474599
- MFCD27976367
- C52H74Cl2O18
- Clostomicin B1
- R-Tiacumicin B
- Lipiarmycin A 3
- Fidaxomicin [USAN]
- Fidaxomicin [USAN:INN]
- UNII-Z5N076G8YQ
- Lipiarrmycin
- PAR 01
- Clostomycin B1
Reported adverse events
- Hypersensitivity
- Nausea
- Neutropenia
- Vomiting
Look up FIDAXOMICIN in the interactive SynDRA portal →